165 related articles for article (PubMed ID: 7120127)
1. Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney.
Stassen FL; Erickson RW; Huffman WF; Stefankiewicz J; Sulat L; Wiebelhaus VD
J Pharmacol Exp Ther; 1982 Oct; 223(1):50-4. PubMed ID: 7120127
[TBL] [Abstract][Full Text] [Related]
2. Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
Stassen FL; Heckman GD; Huffman WF; Kinter LB
J Pharmacol Exp Ther; 1985 Jan; 232(1):100-5. PubMed ID: 3965688
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin-sensitive kidney adenylate cyclase: modulation of the hormonal response.
Roy C
J Supramol Struct; 1976; 4(2):289-303. PubMed ID: 177820
[TBL] [Abstract][Full Text] [Related]
4. Effects of thyroid deficiency on the vasopressin receptors in the kidney of developing and adult rats. A comparative study of hormonal binding and adenylate cyclase activation.
Ali M; Guillon G; Balestre MN; Clos J
Horm Metab Res; 1987 Mar; 19(3):115-21. PubMed ID: 2952571
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.
Caltabiano S; Kinter LB
J Pharmacol Exp Ther; 1991 Sep; 258(3):1046-54. PubMed ID: 1832462
[TBL] [Abstract][Full Text] [Related]
6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
7. Effects of vasopressin antagonist on vasopressin binding, adenylate cyclase activation, and water flux.
Kim JK; Dillingham MA; Summer SN; Ishikawa S; Anderson RJ; Schrier RW
J Clin Invest; 1985 Oct; 76(4):1530-5. PubMed ID: 2997281
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.
Butlen D; Guillon G; Rajerison RM; Jard S; Sawyer WH; Manning M
Mol Pharmacol; 1978 Nov; 14(6):1006-17. PubMed ID: 732809
[No Abstract] [Full Text] [Related]
9. Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
Kinter LB; Churchill S; Stassen FL; Moore M; Huffman W
J Pharmacol Exp Ther; 1987 Jun; 241(3):797-803. PubMed ID: 3598903
[TBL] [Abstract][Full Text] [Related]
10. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
Dousa TP; Valtin H
J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
Jard S; Gaillard RC; Guillon G; Marie J; Schoenenberg P; Muller AF; Manning M; Sawyer WH
Mol Pharmacol; 1986 Aug; 30(2):171-7. PubMed ID: 3016500
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin receptor-adenylate cyclase interactions. Studies in an intact cultured renal epithelial cell line (LLC-PK1).
Skorecki KL; Verkman AS; Ausiello DA
Miner Electrolyte Metab; 1986; 12(1):64-70. PubMed ID: 3007962
[TBL] [Abstract][Full Text] [Related]
13. Activation of rat kidney adenylate cyclase by vasopressin analogues: lack of correlation with antidiuretic activity.
Barth T; Rajerison MR; Roy C; Jard S
Mol Cell Endocrinol; 1975 Jan; 2(2):81-90. PubMed ID: 1149917
[TBL] [Abstract][Full Text] [Related]
14. Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin.
Manning M; Olma A; Klis WA; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1982 Jan; 25(1):45-50. PubMed ID: 7086821
[TBL] [Abstract][Full Text] [Related]
15. Antidiuretic hormone-sensitive kidney adenylate cyclase.
Jard S; Roy C; Barth T; Rajerison R; Bockaert J
Adv Cyclic Nucleotide Res; 1975; 5():31-52. PubMed ID: 165673
[No Abstract] [Full Text] [Related]
16. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
[TBL] [Abstract][Full Text] [Related]
17. Vasotocin-sensitive adenylate cyclase in frog glomeruli.
Ammar A; Roseau S; Butlen D
Gen Comp Endocrinol; 1995 Apr; 98(1):102-10. PubMed ID: 7781959
[TBL] [Abstract][Full Text] [Related]
18. Effects of Ca++ and prostaglandin E1 on vasopressin activation of renal adenyl cyclase.
Marumo F; Edelman IS
J Clin Invest; 1971 Aug; 50(8):1613-20. PubMed ID: 4329002
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of collecting tubules and vasopressin binding capacity in the renal medulla of developing hypothyroid rat.
Ali M; Guillon G; Clos J
J Dev Physiol; 1988 Aug; 10(4):297-308. PubMed ID: 2974464
[TBL] [Abstract][Full Text] [Related]
20. Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonists.
Stassen FL; Bryan W; Gross M; Kavanagh B; Shue D; Sulat L; Wiebelhaus VD; Yim N; Kinter LB
Prog Brain Res; 1983; 60():395-403. PubMed ID: 6665152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
